PMID- 37434265 OWN - NLM STAT- MEDLINE DCOM- 20230713 LR - 20230718 IS - 1749-799X (Electronic) IS - 1749-799X (Linking) VI - 18 IP - 1 DP - 2023 Jul 11 TI - CircZNF367 promotes osteoclast differentiation and osteoporosis by interacting with FUS to maintain CRY2 mRNA stability. PG - 492 LID - 10.1186/s13018-023-03955-7 [doi] LID - 492 AB - BACKGROUND: Osteoporosis, characterized by reduced bone mass and deterioration of bone quality, is a significant health concern for postmenopausal women. Considering that the specific role of circRNAs in osteoporosis and osteoclast differentiation remains poorly understood, this study aims to shed light on their involvement in these processes to enhance our understanding and potentially contribute to improved treatment strategies for osteoporosis. METHODS: An osteoporotic model was constructed in vivo in ovariectomized mouse. In vitro, we induced osteoclast formation in bone marrow-derived macrophages (BMDMs) using M-CSF + RANKL. To assess osteoporosis in mice, we conducted HE staining. We used MTT and TRAP staining to measure cell viability and osteoclast formation, respectively, and also evaluated their mRNA and protein expression levels. In addition, RNA pull-down, RIP and luciferase reporter assays were performed to investigate interactions, and ChIP assay was used to examine the impact of circZNF367 knockdown on the binding between FUS and CRY2. RESULTS: We observed increased expression of CircZNF367, FUS and CRY2 in osteoporotic mice and M-CSF + RANKL-induced BMDMs. Functionally, knocking down circZNF367 inhibited osteoporosis in vivo. Furthermore, interference with circZNF367 suppressed osteoclast proliferation and the expression of TRAP, NFATc1, and c-FOS. Mechanistically, circZNF367 interacted with FUS to maintain CRY2 mRNA stability. Additionally, knocking down CRY2 rescued M-CSF + RANKL-induced osteoclast differentiation in BMDMs promoted by circZNF367 and FUS. CONCLUSION: This study reveals that the circZNF367/FUS axis may accelerate osteoclasts differentiation by upregulating CRY2 in osteoporosis and suggests that targeting circZNF367 may have potential therapeutic effects on osteoporosis. CI - (c) 2023. The Author(s). FAU - Deng, Mingsi AU - Deng M AD - Department of Stomatology, The Third Xiangya Hospital of Central South University, Changsha, 410013, Hunan, People's Republic of China. AD - Department of Orthodontics, Changsha Stomatology Hospital, Changsha, 410005, Hunan, People's Republic of China. FAU - Wang, Zhengguang AU - Wang Z AD - Department of Spine Surgery, The Third Xiangya Hospital of Central South University, Changsha, 410013, Hunan, People's Republic of China. FAU - Luo, Jia AU - Luo J AD - Changsha Blood Center, Changsha, 410001, Hunan, People's Republic of China. FAU - Cao, Heng AU - Cao H AD - The Department of Wound Joint Surgery, Affiliated Hospital of Yiyang Medical College, Yiyang, 413000, Hunan, People's Republic of China. FAU - Li, Yong AU - Li Y AD - Department of Emergency, The Third Xiangya Hospital of Central South University, Changsha, 410013, Hunan, People's Republic of China. FAU - Chen, Liangjian AU - Chen L AD - Department of Stomatology, The Third Xiangya Hospital of Central South University, Changsha, 410013, Hunan, People's Republic of China. FAU - Liu, Gengyan AU - Liu G AD - Department of Orthopedics, The Third Xiangya Hospital, Central South University, No.138, Tongzipo Road, Yuelu District, Changsha, 410013, Hunan, People's Republic of China. liugengyan1102@163.com. LA - eng PT - Journal Article DEP - 20230711 PL - England TA - J Orthop Surg Res JT - Journal of orthopaedic surgery and research JID - 101265112 RN - 81627-83-0 (Macrophage Colony-Stimulating Factor) RN - 0 (RNA, Circular) RN - 0 (FUS protein, mouse) RN - 0 (Cry2 protein, mouse) SB - IM MH - Animals MH - Female MH - Mice MH - Cell Differentiation/genetics MH - Macrophage Colony-Stimulating Factor MH - Osteoclasts MH - *Osteoporosis/genetics MH - RNA Stability/genetics MH - *RNA, Circular/genetics PMC - PMC10334599 OTO - NOTNLM OT - CRY2 OT - CircZNF367 OT - FUS OT - Osteoclast differentiation OT - Osteoporosis COIS- The authors declare no competing interests. EDAT- 2023/07/12 01:07 MHDA- 2023/07/13 06:42 PMCR- 2023/07/11 CRDT- 2023/07/11 23:47 PHST- 2023/02/16 00:00 [received] PHST- 2023/06/23 00:00 [accepted] PHST- 2023/07/13 06:42 [medline] PHST- 2023/07/12 01:07 [pubmed] PHST- 2023/07/11 23:47 [entrez] PHST- 2023/07/11 00:00 [pmc-release] AID - 10.1186/s13018-023-03955-7 [pii] AID - 3955 [pii] AID - 10.1186/s13018-023-03955-7 [doi] PST - epublish SO - J Orthop Surg Res. 2023 Jul 11;18(1):492. doi: 10.1186/s13018-023-03955-7.